Literature DB >> 21357715

Inflammation, the microenvironment and chronic lymphocytic leukemia.

Federico Caligaris-Cappio.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21357715      PMCID： PMC3046264          DOI： 10.3324/haematol.2010.039446

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.

Authors:  J A Burger; N Tsukada; M Burger; N J Zvaifler; M Dell'Aquila; T J Kipps
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.

Authors:  Bradley T Messmer; Davorka Messmer; Steven L Allen; Jonathan E Kolitz; Prasad Kudalkar; Denise Cesar; Elizabeth J Murphy; Prasad Koduru; Manlio Ferrarini; Simona Zupo; Giovanna Cutrona; Rajendra N Damle; Tarun Wasil; Kanti R Rai; Marc K Hellerstein; Nicholas Chiorazzi
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

3.  Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia.

Authors:  L Granziero; P Ghia; P Circosta; D Gottardi; G Strola; M Geuna; L Montagna; P Piccoli; M Chilosi; F Caligaris-Cappio
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

4.  MCP-1 modulates chemotaxis by follicular lymphoma cells.

Authors:  H Husson; E G Carideo; A A Cardoso; S M Lugli; D Neuberg; O Munoz; L de Leval; J Schultze; A S Freedman
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

5.  Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

Authors:  Paolo Ghia; Giuliana Strola; Luisa Granziero; Massimo Geuna; Giuseppe Guida; Federica Sallusto; Nancy Ruffing; Licia Montagna; Paola Piccoli; Marco Chilosi; Federico Caligaris-Cappio
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

6.  Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.

Authors:  Angela Schulz; Grischa Toedt; Thorsten Zenz; Stephan Stilgenbauer; Peter Lichter; Martina Seiffert
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

7.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

9.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.

Authors:  M W Carr; S J Roth; E Luther; S S Rose; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro.

Authors:  L L Xu; M K Warren; W L Rose; W Gong; J M Wang
Journal:  J Leukoc Biol       Date:  1996-09       Impact factor: 4.962
View more
  13 in total

1.  Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL).

Authors:  Michael P Gustafson; Roshini S Abraham; Yi Lin; Wenting Wu; Dennis A Gastineau; Clive S Zent; Allan B Dietz
Journal:  Br J Haematol       Date:  2011-11-03       Impact factor: 6.998

2.  Evaluation of Prognostic Impact of Soluble CD14 in B-Chronic Lymphocytic Leukemia.

Authors:  Waiel Al-Kahiry; Homam Sharshira; Amal Ghanem; Maha El-Gammal; Irene Lewis Mikhael
Journal:  Indian J Hematol Blood Transfus       Date:  2016-11-16       Impact factor: 0.900

Review 3.  T regulatory cells in B-cell malignancy - tumour support or kiss of death?

Authors:  Camilla A Lindqvist; Angelica S I Loskog
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

4.  Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.

Authors:  D Allegra; V Bilan; A Garding; H Döhner; S Stilgenbauer; F Kuchenbauer; D Mertens; M Zucknick
Journal:  Leukemia       Date:  2013-08-26       Impact factor: 11.528

5.  Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues.

Authors:  Bola S Hanna; Philipp M Roessner; Haniyeh Yazdanparast; Dolors Colomer; Elias Campo; Sabrina Kugler; Deyan Yosifov; Stephan Stilgenbauer; Manfred Schmidt; Richard Gabriel; Peter Lichter; Martina Seiffert
Journal:  Leukemia       Date:  2018-09-28       Impact factor: 11.528

6.  Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?

Authors:  Chieko Kyogoku; Biljana Smiljanovic; Joachim R Grün; Robert Biesen; Ursula Schulte-Wrede; Thomas Häupl; Falk Hiepe; Tobias Alexander; Andreas Radbruch; Andreas Grützkau
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  A case of comorbid myxoma and chronic lymphocytic leukemia: not just a coincidence?

Authors:  Heather Laird-Fick; Ashish Tiwari; Santhosshi Narayanan; Ying Qin; Deepthi Vodnala; Manisha Bhutani
Journal:  Case Rep Oncol Med       Date:  2014-04-29

8.  Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study.

Authors:  Marta Solans; Adela Castelló; Yolanda Benavente; Rafael Marcos-Gragera; Pilar Amiano; Esther Gracia-Lavedan; Laura Costas; Claudia Robles; Eva Gonzalez-Barca; Esmeralda de la Banda; Esther Alonso; Marta Aymerich; Elias Campo; Trinidad Dierssen-Sotos; Guillermo Fernández-Tardón; Rocio Olmedo-Requena; Eva Gimeno; Gemma Castaño-Vinyals; Nuria Aragonés; Manolis Kogevinas; Silvia de Sanjose; Marina Pollán; Delphine Casabonne
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

Review 9.  Necroinflammation emerges as a key regulator of hematopoiesis in health and disease.

Authors:  Philipp J Jost; Ulrike Höckendorf
Journal:  Cell Death Differ       Date:  2018-09-21       Impact factor: 15.828

10.  Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL).

Authors:  Andrea Sitlinger; Michael A Deal; Erwin Garcia; Dana K Thompson; Tiffany Stewart; Grace A MacDonald; Nicolas Devos; David Corcoran; Janet S Staats; Jennifer Enzor; Kent J Weinhold; Danielle M Brander; J Brice Weinberg; David B Bartlett
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.